資源 » 參考數(shù)據(jù)庫 » 客戶發(fā)表文獻(xiàn)

至今，GenScript的服務(wù)及產(chǎn)品已被Cell, Nature, Science, PNAS等1300多家生物醫(yī)藥類雜志引用近萬次，處于行業(yè)領(lǐng)先水平。NIH、哈佛、耶魯、斯坦福、普林斯頓、杜克大學(xué)等約400家全球著名機(jī)構(gòu)使用GenScript的基因合成、多肽服務(wù)、抗體服務(wù)和蛋白服務(wù)等成功地發(fā)表科研成果，再次證明GenScript 有能力幫助業(yè)內(nèi)科學(xué)家Make research easy.

Generation of antibody-based therapeutics targeting the Idiotype of B-cell Malignancies.

Antib Ther. 2019-01;

WeissEmily, SarnovskyRobert, HoMitchell, AronsEvgeny, KreitmanRobert, AngelusEvan, AntignaniAntonella, FitzGeraldD

Products/Services Used	Details	Operation
Catalog Antibody	… by DNA synthesis (Blue Heron Biotech), and include an OmpA periplasm directing signal sequence (cleaved upon entry in the periplasm), followed by a FLAG tag epitope (DYKDDDDK) to allow binding to an anti-FLAG affinity purification resin (Genscript catalog #L00432), the …	Get A Quote

摘要

A feature of many B-cell tumors is a surface-expressed immunoglobulin (sIg). The complementarity determiningregions (CDRs)of the sIg， termed the 'idiotype'， are unique to each tumor. We report on a phage selection strategy to generate anti-idiotype therapeutics that react with sIg CDR3 sequences: the MEC1 B-cell tumor line was used as proof of concept.